| Literature DB >> 9526730 |
K Sano1, S Yoshida, H Ninomiya, H Ikeda, K Ueno, J Sekine, H Iwamoto, M Uehara, T Inokuchi.
Abstract
Specimens from two ameloblastic fibromas (including one recurrent case), two ameloblastic fibro-odontomas, and one ameloblastic fibrosarcoma were subjected to investigation by MIB-1 immunohistochemistry in order to elucidate the growth potential of these tumors. MIB-1 labeling indices in the epithelial component of these tumors ranged from 2.9 to 7.5%, whereas those in the mesenchymal component ranged from 1.5 to 13.5%. Of these, labeling indices in the mesenchymal component of the recurrent ameloblastic fibroma and ameloblastic fibrosarcoma were quite high. These findings suggest that evaluation of growth potential in ameloblastic fibroma and related lesions could be of help in understanding tumor aggressiveness and in selecting appropriate surgical procedures.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9526730 DOI： 10.1111/j.1600-0714.1998.tb02094.x
Source DB: PubMed Journal: J Oral Pathol Med ISSN： 0904-2512 Impact factor: 4.253